参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/01 | 1,505 | 1,534 | 1,505 | 1,530 | +31 | +2.1% | 794,400 |
2019/01/31 | 1,519 | 1,525 | 1,496 | 1,499 | -21 | -1.4% | 1,166,700 |
2019/01/30 | 1,504 | 1,537 | 1,502 | 1,520 | +19 | +1.3% | 1,641,300 |
2019/01/29 | 1,490 | 1,503 | 1,478 | 1,501 | +11 | +0.7% | 1,394,000 |
2019/01/28 | 1,495 | 1,504 | 1,480 | 1,490 | -17 | -1.1% | 1,235,100 |
2019/01/25 | 1,505 | 1,524 | 1,501 | 1,507 | -5 | -0.3% | 865,000 |
2019/01/24 | 1,503 | 1,521 | 1,490 | 1,512 | ±0 | ±0% | 1,038,200 |
2019/01/23 | 1,518 | 1,523 | 1,505 | 1,512 | -11 | -0.7% | 1,036,400 |
2019/01/22 | 1,545 | 1,545 | 1,515 | 1,523 | -2 | -0.1% | 779,800 |
2019/01/21 | 1,550 | 1,558 | 1,518 | 1,525 | +6 | +0.4% | 1,254,800 |
2019/01/18 | 1,522 | 1,534 | 1,513 | 1,519 | +13 | +0.9% | 1,389,100 |
2019/01/17 | 1,507 | 1,512 | 1,483 | 1,506 | -2 | -0.1% | 1,405,800 |
2019/01/16 | 1,500 | 1,519 | 1,492 | 1,508 | +28 | +1.9% | 1,859,200 |
2019/01/15 | 1,513 | 1,519 | 1,470 | 1,480 | -60 | -3.9% | 2,626,900 |
2019/01/11 | 1,580 | 1,586 | 1,532 | 1,540 | -46 | -2.9% | 1,751,700 |
2019/01/10 | 1,602 | 1,612 | 1,574 | 1,586 | -73 | -4.4% | 1,871,500 |
2019/01/09 | 1,626 | 1,677 | 1,620 | 1,659 | +50 | +3.1% | 1,631,900 |
2019/01/08 | 1,627 | 1,638 | 1,598 | 1,609 | -12 | -0.7% | 1,401,200 |
2019/01/07 | 1,623 | 1,633 | 1,598 | 1,621 | +38 | +2.4% | 1,108,500 |
2019/01/04 | 1,544 | 1,585 | 1,528 | 1,583 | -3 | -0.2% | 1,317,600 |
2018/12/28 | 1,618 | 1,620 | 1,573 | 1,586 | -47 | -2.9% | 925,600 |
2018/12/27 | 1,591 | 1,645 | 1,585 | 1,633 | +97 | +6.3% | 962,800 |
2018/12/26 | 1,528 | 1,570 | 1,515 | 1,536 | +14 | +0.9% | 799,900 |
2018/12/25 | 1,610 | 1,613 | 1,509 | 1,522 | -123 | -7.5% | 1,515,500 |
2018/12/21 | 1,700 | 1,700 | 1,640 | 1,645 | -55 | -3.2% | 1,600,400 |
2018/12/20 | 1,727 | 1,749 | 1,700 | 1,700 | -42 | -2.4% | 919,100 |
2018/12/19 | 1,741 | 1,757 | 1,719 | 1,742 | +5 | +0.3% | 1,052,200 |
2018/12/18 | 1,762 | 1,774 | 1,737 | 1,737 | -62 | -3.4% | 939,600 |
2018/12/17 | 1,793 | 1,806 | 1,783 | 1,799 | -17 | -0.9% | 670,700 |
2018/12/14 | 1,820 | 1,837 | 1,811 | 1,816 | -8 | -0.4% | 1,211,300 |
2018/12/13 | 1,825 | 1,832 | 1,798 | 1,824 | +4 | +0.2% | 927,100 |
2018/12/12 | 1,800 | 1,832 | 1,792 | 1,820 | +18 | +1% | 1,254,200 |
2018/12/11 | 1,829 | 1,829 | 1,797 | 1,802 | -15 | -0.8% | 626,400 |
2018/12/10 | 1,846 | 1,846 | 1,808 | 1,817 | -53 | -2.8% | 764,200 |
2018/12/07 | 1,866 | 1,879 | 1,849 | 1,870 | +19 | +1% | 880,100 |
2018/12/06 | 1,877 | 1,893 | 1,832 | 1,851 | -61 | -3.2% | 1,019,700 |
2018/12/05 | 1,864 | 1,918 | 1,863 | 1,912 | +12 | +0.6% | 740,600 |
2018/12/04 | 1,930 | 1,937 | 1,900 | 1,900 | -47 | -2.4% | 830,300 |
2018/12/03 | 1,973 | 1,988 | 1,938 | 1,947 | +4 | +0.2% | 1,003,200 |
2018/11/30 | 1,897 | 1,945 | 1,890 | 1,943 | +6 | +0.3% | 1,775,500 |
2018/11/29 | 1,910 | 1,957 | 1,909 | 1,937 | +61 | +3.3% | 1,133,400 |
2018/11/28 | 1,890 | 1,907 | 1,874 | 1,876 | +32 | +1.7% | 1,378,100 |
2018/11/27 | 1,866 | 1,866 | 1,836 | 1,844 | -23 | -1.2% | 607,800 |
2018/11/26 | 1,850 | 1,873 | 1,850 | 1,867 | +17 | +0.9% | 743,400 |
2018/11/22 | 1,806 | 1,856 | 1,806 | 1,850 | +56 | +3.1% | 777,500 |
2018/11/21 | 1,774 | 1,800 | 1,771 | 1,794 | -8 | -0.4% | 785,000 |
2018/11/20 | 1,827 | 1,831 | 1,795 | 1,802 | -45 | -2.4% | 1,131,500 |
2018/11/19 | 1,843 | 1,851 | 1,825 | 1,847 | -12 | -0.6% | 891,400 |
2018/11/16 | 1,838 | 1,871 | 1,829 | 1,859 | +31 | +1.7% | 938,800 |
2018/11/15 | 1,791 | 1,834 | 1,780 | 1,828 | +21 | +1.2% | 958,300 |
1601~
1650
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ロート | 253,900円 | +8.4% | +6.4% | 1.65% | 18.21倍 | 2.21倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム